NCT06520904View on ClinicalTrials.gov

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography

PHASE4RecruitingINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Coronary Artery DiseaseOptical Coherence Tomography
Interventions
DRUG

PCSK9 inhibitor

PCSK9 inhibitors combined with moderate-intensity statin therapy

DRUG

Statin

Intensive statin therapy

Trial Locations (1)

830011

RECRUITING

First Affiliated Hospital of Xinjiang Medical University, Ürümqi

All Listed Sponsors
lead

First Affiliated Hospital of Xinjiang Medical University

OTHER